SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-17-002847
Filing Date
2017-03-24
Accepted
2017-03-24 19:42:03
Documents
1
Period of Report
2016-10-19

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 2406
  Complete submission text file 0001493152-17-002847.txt   3999
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Issuer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2860 Industrial Organic Chemicals

Mailing Address 62 HOOK AVENUE TORONTO A6 M6P IT4
Business Address
Campbell Vyvyan (Reporting) CIK: 0001700395 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52445 | Film No.: 17713909